C

Catalyst Pharmaceuticals
D

CPRX

25.060
USD
-0.15
(-0.60%)
مغلق
حجم التداول
32,282
الربح لكل سهم
2
العائد الربحي
-
P/E
15
حجم السوق
3,080,184,418
أصول ذات صلة المقالات

العنوان: Catalyst Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).